| Breakdown | TTM | Dec 2025 | Dec 2024 | Dec 2023 | Dec 2022 | Dec 2021 |
|---|---|---|---|---|---|---|
Income Statement | ||||||
| Total Revenue | 1.00T | 1.03T | 1.07T | 1.14T | 1.10T | 1.02T |
| Gross Profit | 98.86B | 100.12B | 109.57B | 116.79B | 110.57B | 97.88B |
| EBITDA | 38.28B | 67.55B | 65.74B | 67.59B | 64.21B | 59.25B |
| Net Income | 18.74B | 18.36B | 22.22B | 26.10B | 26.68B | 24.69B |
Balance Sheet | ||||||
| Total Assets | 2.14T | 2.08T | 1.86T | 1.66T | 1.52T | 1.35T |
| Cash, Cash Equivalents and Short-Term Investments | 178.65B | 192.93B | 187.24B | 168.59B | 159.39B | 127.28B |
| Total Debt | 805.99B | 550.08B | 424.38B | 282.57B | 260.86B | 232.23B |
| Total Liabilities | 1.77T | 1.66T | 1.44T | 1.25T | 1.14T | 1.01T |
| Stockholders Equity | 277.00B | 340.29B | 328.25B | 309.84B | 290.48B | 268.79B |
Cash Flow | ||||||
| Free Cash Flow | -71.33B | -44.64B | -69.37B | -14.51B | 25.87B | -40.18B |
| Operating Cash Flow | -19.41B | 2.96B | -31.42B | 20.41B | 56.13B | -7.30B |
| Investing Cash Flow | -58.37B | -56.96B | -48.04B | -55.91B | -55.65B | -61.07B |
| Financing Cash Flow | 94.89B | 59.83B | 94.76B | 44.59B | 33.89B | 10.60B |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
66 Neutral | HK$47.70B | 3.19 | 11.89% | 6.69% | -5.48% | -4.24% | |
63 Neutral | $10.79B | 15.43 | 7.44% | 2.01% | 2.89% | -14.66% | |
63 Neutral | HK$25.35B | 16.82 | 5.64% | 5.31% | 9.27% | -27.28% | |
57 Neutral | HK$85.57B | 8.64 | 4.96% | 3.90% | 5.40% | -33.06% | |
57 Neutral | HK$62.89B | 4.48 | 0.95% | 3.21% | -17.50% | -75.50% | |
53 Neutral | HK$96.28B | 3.57 | 5.70% | 5.92% | -2.50% | -10.45% | |
52 Neutral | HK$18.11B | 22.20 | 6.83% | ― | -3.56% | 49.92% |